Cargando…

Immunologic Monitoring of Cellular Immune Responses in Cancer Vaccine Therapy

Detalles Bibliográficos
Autores principales:	Whiteside, Theresa L., Gulley, James L., Clay, Timothy M., Tsang, Kwong Yok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114594/ https://www.ncbi.nlm.nih.gov/pubmed/21687551 http://dx.doi.org/10.1155/2011/370374

Ejemplares similares

Proteomic Analysis of Plasma-Derived Exosomes in Defining Their Role as Biomarkers of Disease Progression, Response to Therapy and Outcome
por: Whiteside, Theresa L.
Publicado: (2019)

The role of regulatory T cells in cancer immunology
por: Whiteside, Theresa L
Publicado: (2015)

Poxviral-based vaccine elicits immunologic responses in prostate cancer patients
por: Madan, Ravi A, et al.
Publicado: (2014)

Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies
por: Dominguez, Charli, et al.
Publicado: (2016)

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein
por: Jochems, Caroline, et al.
Publicado: (2013)

The amalgamation of cellular metabolism and immunology for host immunity
por: Mintern, Justine D, et al.
Publicado: (2020)

Immunologic Monitoring of Cellular Responses by Dendritic/Tumor Cell Fusion Vaccines
por: Koido, Shigeo, et al.
Publicado: (2011)

Cellular Immunology and COVID-19
por: Quinti, Isabella
Publicado: (2021)

Innate and Cellular Immunology in Parasitic Diseases
por: Terrazas, Luis I., et al.
Publicado: (2011)

The Consequence of Immune Suppressive Cells in the Use of Therapeutic Cancer Vaccines and Their Importance in Immune Monitoring
por: Vergati, Matteo, et al.
Publicado: (2011)

Systemic immunological biomarkers of clinical responses in immune checkpoint blockade therapies
por: Arasanz, Hugo, et al.
Publicado: (2018)

Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy
por: Gill, Harinder, et al.
Publicado: (2016)

Vaccine Response in the Immunocompromised Patient with Focus on Cellular Immunity
por: Bahrs, Christina, et al.
Publicado: (2022)

Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis
por: Gatti-Mays, Margaret, et al.
Publicado: (2021)

Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells
por: Lepone, Lauren, et al.
Publicado: (2015)

Immunotherapy: Shifting the Balance of Cell-Mediated Immunity and Suppression in Human Prostate Cancer
por: Tucker, Jo A., et al.
Publicado: (2012)

EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment
por: Kimura, Hiroshi, et al.
Publicado: (2019)

Immunological Responses to Cancer Therapy
por: Fransen, Marieke F.
Publicado: (2022)

Immunological monitoring for prediction of clinical response to antitumor vaccine therapy
por: Mikhaylova, Irina N., et al.
Publicado: (2018)

Still puzzling questions in immunology (infection and immunity)
por: Garraud, Olivier, et al.
Publicado: (2015)

Immune Responses to Cancer: Are They Potential Biomarkers of Prognosis?
por: Whiteside, Theresa L.
Publicado: (2013)

Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?
por: Whiteside, T L
Publicado: (2005)

Investigation of antibody dependent cellular cytotoxicity as a mechanism of action for a novel anti-PD-L1 monoclonal antibody
por: Boyerinas, Benjamin, et al.
Publicado: (2014)

The potential of microRNA carried by small extracellular vesicles in cancer plasma to serve as cancer biomarkers
por: Whiteside, Theresa L.
Publicado: (2023)

Molecular Immunology in Bacterial Vaccine Discovery
por: Berisio, Rita
Publicado: (2022)

Celebrating a decade of the Journal for ImmunoTherapy of Cancer
por: Romero, Pedro J, et al.
Publicado: (2022)

Recent progress in mucosal immunology and vaccine development
por: Kweon, Mi-Na
Publicado: (2014)

Immunotherapy for acute leukemia
por: Boyiadzis, Michael, et al.
Publicado: (2015)

The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic
por: Gabitzsch, Elizabeth S., et al.
Publicado: (2015)

In memoriam: Soldano Ferrone, MD, PhD (1940–2023)
por: Whiteside, Theresa, et al.
Publicado: (2023)

Avelumab demonstrates promise in advanced NSCLC
por: Marciscano, Ariel E., et al.
Publicado: (2017)

Checkpoint and PARP inhibitors, for whom and when
por: Lee, Jung-Min, et al.
Publicado: (2017)

Developing immunotherapy strategies in the treatment of prostate cancer
por: Gulley, James L., et al.
Publicado: (2016)

High levels of expression of the transcription factor Brachyury induce resistance of human carcinoma cells to immune-mediated attack
por: Hamilton, Duane H, et al.
Publicado: (2013)

Cancer Immunology and Immunotherapies: Mechanisms That Affect Antitumor Immune Response and Treatment Resistance
por: Zhao, Xianda, et al.
Publicado: (2021)

Tumor-Derived Exosomes and Their Role in Tumor-Induced Immune Suppression
por: Whiteside, Theresa L.
Publicado: (2016)

Immunological targets for cancer therapy: new recognition
por: Shurin, Michael R
Publicado: (2018)

Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity
por: Madan, Ravi A, et al.
Publicado: (2012)

Targeting breast cancer vaccines to dendritic cells: improved immunological responses with less protein?
por: Armstrong, Anne C, et al.
Publicado: (2012)

The Role of Tumor-Derived Exosomes (TEX) in Shaping Anti-Tumor Immune Competence
por: Whiteside, Theresa L.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0gp3pprluipfcu6ss0jqsdm9rk